Annual FCF
-$44.17 M
+$8.25 M+15.74%
December 1, 2024
Summary
- As of March 12, 2025, JANX annual free cash flow is -$44.17 million, with the most recent change of +$8.25 million (+15.74%) on December 1, 2024.
- During the last 3 years, JANX annual FCF has fallen by -$25.71 million (-139.32%).
- JANX annual FCF is now -1053.94% below its all-time high of -$3.83 million, reached on December 31, 2019.
Performance
JANX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$16.77 M
-$14.51 M-643.22%
December 1, 2024
Summary
- As of March 12, 2025, JANX quarterly free cash flow is -$16.77 million, with the most recent change of -$14.51 million (-643.22%) on December 1, 2024.
- Over the past year, JANX quarterly FCF has stayed the same.
- JANX quarterly FCF is now -409.93% below its all-time high of $5.41 million, reached on March 31, 2021.
Performance
JANX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$44.17 M
-$6.35 M-16.79%
December 1, 2024
Summary
- As of March 12, 2025, JANX TTM free cash flow is -$44.17 million, with the most recent change of -$6.35 million (-16.79%) on December 1, 2024.
- Over the past year, JANX TTM FCF has stayed the same.
- JANX TTM FCF is now -2404.28% below its all-time high of $1.92 million, reached on March 31, 2021.
Performance
JANX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
JANX Free Cash Flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +15.7% | 0.0% | 0.0% |
3 y3 years | -139.3% | 0.0% | 0.0% |
5 y5 years | -1053.9% | 0.0% | 0.0% |
JANX Free Cash Flow Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -139.3% | +15.7% | -643.2% | at low | -139.3% | +26.1% |
5 y | 5-year | -1053.9% | +15.7% | -409.9% | at low | -2404.3% | +26.1% |
alltime | all time | -1053.9% | +15.7% | -409.9% | at low | -2404.3% | +26.1% |
Janux Therapeutics Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | -$44.17 M(-15.7%) | -$16.77 M(+643.2%) | -$44.17 M(+16.8%) |
Sep 2024 | - | -$2.26 M(-77.7%) | -$37.82 M(-20.8%) |
Jun 2024 | - | -$10.12 M(-32.7%) | -$47.74 M(-10.4%) |
Mar 2024 | - | -$15.03 M(+44.3%) | -$53.26 M(+1.6%) |
Dec 2023 | -$52.42 M(+6.2%) | -$10.42 M(-14.5%) | -$52.42 M(-6.3%) |
Sep 2023 | - | -$12.18 M(-22.1%) | -$55.98 M(-6.3%) |
Jun 2023 | - | -$15.63 M(+10.1%) | -$59.73 M(+17.0%) |
Mar 2023 | - | -$14.20 M(+1.6%) | -$51.07 M(+3.4%) |
Dec 2022 | -$49.37 M | -$13.97 M(-12.3%) | -$49.37 M(+4.9%) |
Sep 2022 | - | -$15.93 M(+128.6%) | -$47.05 M(+27.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2022 | - | -$6.97 M(-44.2%) | -$37.05 M(+1.9%) |
Mar 2022 | - | -$12.49 M(+7.2%) | -$36.36 M(+97.0%) |
Dec 2021 | -$18.46 M(+322.5%) | -$11.65 M(+96.5%) | -$18.46 M(+118.9%) |
Sep 2021 | - | -$5.93 M(-5.6%) | -$8.43 M(+135.2%) |
Jun 2021 | - | -$6.28 M(-216.1%) | -$3.58 M(-287.0%) |
Mar 2021 | - | $5.41 M(-432.1%) | $1.92 M(-143.9%) |
Dec 2020 | -$4.37 M(+14.1%) | -$1.63 M(+50.4%) | -$4.37 M(+59.5%) |
Sep 2020 | - | -$1.08 M(+38.7%) | -$2.74 M(+65.4%) |
Jun 2020 | - | -$781.00 K(-10.8%) | -$1.66 M(+89.2%) |
Mar 2020 | - | -$876.00 K | -$876.00 K |
Dec 2019 | -$3.83 M | - | - |
FAQ
- What is Janux Therapeutics annual free cash flow?
- What is the all time high annual FCF for Janux Therapeutics?
- What is Janux Therapeutics annual FCF year-on-year change?
- What is Janux Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Janux Therapeutics?
- What is Janux Therapeutics quarterly FCF year-on-year change?
- What is Janux Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Janux Therapeutics?
- What is Janux Therapeutics TTM FCF year-on-year change?
What is Janux Therapeutics annual free cash flow?
The current annual FCF of JANX is -$44.17 M
What is the all time high annual FCF for Janux Therapeutics?
Janux Therapeutics all-time high annual free cash flow is -$3.83 M
What is Janux Therapeutics annual FCF year-on-year change?
Over the past year, JANX annual free cash flow has changed by +$8.25 M (+15.74%)
What is Janux Therapeutics quarterly free cash flow?
The current quarterly FCF of JANX is -$16.77 M
What is the all time high quarterly FCF for Janux Therapeutics?
Janux Therapeutics all-time high quarterly free cash flow is $5.41 M
What is Janux Therapeutics quarterly FCF year-on-year change?
Over the past year, JANX quarterly free cash flow has changed by $0.00 (0.00%)
What is Janux Therapeutics TTM free cash flow?
The current TTM FCF of JANX is -$44.17 M
What is the all time high TTM FCF for Janux Therapeutics?
Janux Therapeutics all-time high TTM free cash flow is $1.92 M
What is Janux Therapeutics TTM FCF year-on-year change?
Over the past year, JANX TTM free cash flow has changed by $0.00 (0.00%)